Taking the above into consideration, it can be anticipated that TACI-APRIL interaction may also contribute to the immunosuppressive tumour microenvironment in CLL, and if this happens, CLL patients with genotypes associated with higher expression of APRIL and/or TACI may progress to more aggressive forms of CLL. The gene discussed is TNFRSF13B; the disease is B-cell chronic lymphocytic leukemia.